Skip to main content

Advertisement

SpringerLink
Log in

Incidence of Postoperative Pancreatic Fistula and Hyperamylasemia after Cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy

  • Gastrointestinal Oncology
  • Original Papers
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Introduction

The purpose of this study was to analyze the postoperative pancreatic morbidity of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of peritoneal surface malignancies (PSM).

Patients and methods

Two hundred and sixty five patients (87M/178F) with PSM underwent 270 consecutive procedures. The mean age was 52 years (range: 22–79 years). CRS was performed using peritonectomy procedures. HIPEC through the closed abdomen technique was conducted using cisplatin (CDDP 25mg/m2/L of perfusate)+mitomycin C (MMC 3.3 mg/m2/L of perfusate) or CDDP (43mg/L of perfusate)+doxorubicin (Dx 15.25 mg/L of perfusate), at 42.5°C. Diagnosis and classification of postoperative pancreatic fistula (POPF) were performed according to the international study group on pancreatic fistula criteria. Serum amylase alterations were graded according to the National Cancer Institute (NCI) common terminology criteria for adverse events (CTCAE) v3.

Results

POPF was observed in 13 (4.8%) cases. Three cases were classified as major (grade C). Two cases presented postoperative pancreatitis. G3-4 alteration of amylase was observed in 12.3% of the cases. Performing splenectomy and CDDP dosage for HIPEC >240mg were proven to be independent risk factors for both G3-4 hyperamylasemia and POPF.

Conclusions

CRS+HIPEC presented an acceptable rate of pancreatic morbidity which did not contribute to the mortality related to the procedure. Most of the POPF were mild and/or easily controlled by conservative measures. Although not specific a normal amylasemia could be a useful marker of pancreatic integrity after CRS+HIPEC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Deraco M, Baratti D, Inglese MG, Allaria B, Andreola S, Gavazzi C, Kusamura S. Peritonectomy and intraperitoneal hyperthermic perfusion (IPHP): a strategy that has confirmed its efficacy in patients with pseudomyxoma peritonei. Ann Surg Oncol 2004; 11(4):393–8

    Article  PubMed  Google Scholar 

  2. Deraco M, Casali P, Inglese MG, Baratti D, Pennacchioli E, Bertulli R, Kusamura S. Peritoneal mesothelioma treated by induction chemotherapy, cytoreductive surgery, and intraperitoneal hyperthermic perfusion. J Surg Oncol 2003; 83:147–53

    Article  PubMed  Google Scholar 

  3. Ryu KS, Kim JH, Ko HS, Kim JW, Ahn WS, Park YG, Kim SJ, Lee JM. Effects of intraperitoneal hyperthermic chemotherapy in ovarian cancer. Gynecol Oncol 2004; 94:325–32

    Article  PubMed  CAS  Google Scholar 

  4. Glehen O, Kwiatkowski F, Sugarbaker PH, Elias D, Levine EA, De Simone M, Barone R, Yonemura Y, Cavaliere F, Quenet F, Gutman M, Tentes AA, Lorimier G, Bernard JL, Bereder JM, Porcheron J, Gomez-Portilla A, Shen P, Deraco M, Rat P. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol 2004; 22:3284–92

    Article  PubMed  CAS  Google Scholar 

  5. Verwaal VJ, van Ruth S, de Bree E, van Sloothen GW, van Tinteren H, Boot H, Zoetmulder FA. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 2003; 21:3737–43

    Article  PubMed  Google Scholar 

  6. Jacquet P, Stephens AD, Averbach AM, Chang D, Ettinghausen SE, Dalton RR, Steves MA, Sugarbaker PH. Analysis of morbidity and mortality in 60 patients with peritoneal. carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy. Cancer 1996; 77:2622–9

    Article  PubMed  CAS  Google Scholar 

  7. Stephens AD, Alderman R, Chang D, Edwards GD, Esquivel J, Sebbag G, Steves MA, Sugarbaker PH. Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol 1999; 6:790–6

    Article  PubMed  CAS  Google Scholar 

  8. Glehen O, Osinsky D, Cotte E, Kwiatkowski F, Freyer G, Isaac S, Trillet-Lenoir V, Sayag-Beaujard AC, Francois Y, Vignal J, Gilly FN. Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: morbidity and mortality analysis of 216 consecutive procedures. Ann Surg Oncol 2003; 10:863–9

    Article  PubMed  CAS  Google Scholar 

  9. Verwaal VJ, van Tinteren H, Ruth SV, Zoetmulder FA. Toxicity of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy. J Surg Oncol 2004; 85:61–7

    Article  PubMed  Google Scholar 

  10. Shen P, Hawksworth J, Lovato J, Loggie BW, Geisinger KR, Fleming RA, Levine EA. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis from nonappendiceal colorectal carcinoma. Ann Surg Oncol 2004; 11:178–86

    Article  PubMed  Google Scholar 

  11. Kusamura S, Younan R, Baratti D, Costanzo P, Favaro M, Gavazzi C, Deraco M. Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion: analysis of morbidity and mortality in 209 peritoneal surface malignancies treated with closed abdomen technique. Cancer 2006; 106(5):1144–53

    Article  PubMed  Google Scholar 

  12. Tansung T, Sugarbaker PH. Management of pancreatitis due to pancreatic injury in cytoreductive surgery. Reg Cancer Treat 1995; 8:180–4

    Google Scholar 

  13. Sugarbaker PH. Peritonectomy procedures. Ann Surg 1995; 221:29–42

    Article  PubMed  CAS  Google Scholar 

  14. Sugarbaker PH. Laser-mode electrosurgery. Cancer Treat Res 1996; 82:375–85

    PubMed  CAS  Google Scholar 

  15. Younan R, Kusamura S, Baratti D, Oliva GD, Costanzo P, Favaro M, Gavazzi C, Deraco M. Bowel complications in 203 cases of peritoneal surface malignancies treated with peritonectomy and closed-technique intraperitoneal hyperthermic perfusion. Ann Surg Oncol 2005; 12(11):910–8

    Article  PubMed  Google Scholar 

  16. Jacquet P, Sugarbaker PH. Current methodologies for clinical assessment of patients with peritoneal carcinomatosis. J Exp Clin Cancer Res 1996; 15:49–58

    Google Scholar 

  17. Fujimoto S, Takahashi M, Kobayashi K, Kure M, Masaoka H, Ohkubo H, Isaka S, Shimazaki J. Combined treatment of pelvic exenterative surgery and intra-operative pelvic hyperthermochemotherapy for locally advanced rectosigmoid cancer: report of a case. Surg Today 1993; 23:1094–8

    Article  PubMed  CAS  Google Scholar 

  18. Rossi CR, Foletto M, Mocellin S, Pilati P, De SM, Deraco M, Cavaliere F, Palatini P, Guasti F, Scalerta R, Lise M. Hyperthermic intraoperative intraperitoneal chemotherapy with cisplatin and doxorubicin in patients who undergo cytoreductive surgery for peritoneal carcinomatosis and sarcomatosis: phase I study. Cancer 2002; 94:492–9

    Article  PubMed  CAS  Google Scholar 

  19. Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J, Neoptolemos J, Sarr M, Traverso W, Buchler M. International Study Group on Pancreatic Fistula Definition. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 2005; 138(1):8–13

    Article  PubMed  Google Scholar 

  20. Swaroop VS, Chari ST, Clain JE. Severe acute pancreatitis. JAMA 2004; 291(23):2865–8

    Article  PubMed  CAS  Google Scholar 

  21. Dawson-Saunders B, Trapp RG. Basic and Clinical Biostatistics, Second Edition. Norwalk, Connecticut. Appleton & Lange

  22. http://www.peritonealworkshop2006.com, last access April 2007

  23. Chand B, Walsh RM, Ponsky J, Brody F. Pancreatic complications following laparoscopic splenectomy. Surg Endosc 2001; 15(11):1273–6

    Article  PubMed  CAS  Google Scholar 

  24. Delaitre B, Champault G, Barrat C, Gossot D, Bresler L, Meyer C, Collet D, Samama G. Laparoscopic splenectomy for hematologic diseases. Study of 275 cases. French Society of Laparoscopic Surgery. Ann Chir 2000; 125(6):522–9. French

    Article  PubMed  CAS  Google Scholar 

  25. Hendricks T, Martens MF, Huyben CM, Wobbes T. Inhibition of basal and TGF beta-induced fibroblast collagen synthesis by antineoplastic agents. Implications for wound healing. Br J Cancer 1993; 67(3):545–50

    PubMed  CAS  Google Scholar 

  26. Rattner DW, Gu ZY, Vlahakes GJ, Warshaw AL. Hyperamylasemia after cardiac surgery. Incidence, significance, and management. Ann Surg 1989; 209(3):279–83

    Article  PubMed  CAS  Google Scholar 

  27. Hashimoto N, Haji S, Nomura H, Ohyanagi H. Hyperamylasemia after hepatic resection. Hepatogastroenterology 2003; 50(53):1472–3

    PubMed  Google Scholar 

  28. Baniel J, Leibovitch I, Foster RS, Rowland RG, Bihrle R, Donohue JP. Hyperamylasemia after post-chemotherapy retroperitoneal lymph node dissection for testis cancer. J Urol 1995; 154(4):1373–5

    Article  PubMed  CAS  Google Scholar 

  29. Korenaga D, Watanabe A, Baba H, Saito A, Maehara Y, Sugimachi K. Hyperamylasemia associated with lymphadenectomy in patients surgically treated for gastric cancer. Eur J Surg Oncol 1992; 18(2):135–41

    PubMed  CAS  Google Scholar 

  30. Leclerc P, Forest JC. Variations in amylase isoenzymes and lipase during acute pancreatitis, and in other disorders causing hyperamylasemia. Clin Chem 1983; 29(6):1020–3

    PubMed  CAS  Google Scholar 

  31. Baronofsky ID, Wwalton W, Noble JF. Occult injury to the pancreas following splenectomy. Surgery 1951; 29(6):852–7

    PubMed  CAS  Google Scholar 

  32. Paajanen H, Nuutinen P, Harmoinen A, Poyhonen M, Pitkanen O, Nordback I, Gronroos J, Nevalainen TJ. Hyperamylasemia after cardiopulmonary bypass: pancreatic cellular injury or impaired renal excretion of amylase? Surgery 1998; 123(5):504–10

    Article  PubMed  CAS  Google Scholar 

  33. Li-Ling J, Irving M. Somatostatin and octreotide in the prevention of postoperative pancreatic complications and the treatment of enterocutaneous pancreatic fistulas: a systematic review of randomized controlled trials. Br J Surg 2001; 88(2):190–9

    Article  PubMed  CAS  Google Scholar 

  34. Balcom JH 4th, Keck T, Warshaw AL, Graeme-Cook F, Fernandez-del Castillo C. Prevention of pancreatic fistula with a new synthetic, absorbable sealant: evaluation in a dog model. J Am Coll Surg 2002; 195(4):490–6

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

Supported in part by grants from the Associazione Italiana Ricerca sul Cancro (AIRC).

Author information

Authors and Affiliations

  1. Dept of Surgery, National Cancer Institute of Milan, Milan, Italy

    Shigeki Kusamura MD, PhD, Dario Baratti MD, Adelmo Antonucci MD, Barbara Laterza MD, Grazia Daniela Oliva MD & Marcello Deraco MD

  2. Nutritional Care Unit, National Cancer Institute of Milan, Milan, Italy

    Cecilia Gavazzi MD

  3. Dept of Surgery – Surgical Oncology Unit, CHUM, University of Montreal Health Centre, Montreal, Canada

    Rami Younan MD

  4. Istituto Nazionale Tumori Milano, Via Venezian 1, 20133, Milano, Italia

    Marcello Deraco MD

Authors
  1. Shigeki Kusamura MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dario Baratti MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Adelmo Antonucci MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rami Younan MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Barbara Laterza MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Grazia Daniela Oliva MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Cecilia Gavazzi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Marcello Deraco MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marcello Deraco MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kusamura, S., Baratti, D., Antonucci, A. et al. Incidence of Postoperative Pancreatic Fistula and Hyperamylasemia after Cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy. Ann Surg Oncol 14, 3443–3452 (2007). https://doi.org/10.1245/s10434-007-9551-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-007-9551-0

Keywords

Search

Navigation